At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 23 enrolled
Drug / intervention
lisinopril +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind Pilot Study to Measure the Effect of Lisinopril vs. Placebo on Pulmonary Distress in Patients Receiving External Beam Radiotherapy to the Lung
In Brief
A Phase 2 clinical trial evaluating lisinopril and placebo for Dyspnea and 2 related conditions. Completed, enrolled 23 participants across 3 sites.
Detailed Summary
This pilot clinical trial studies lisinopril in reducing shortness of breath caused by radiation therapy in patients with lung cancer. Lisinopril may decrease the side effects caused by radiation therapy in patients with lung cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspnea, Non-small Cell Lung Cancer, Small Cell Lung Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
Primary CompletionJun 2013
First PostedJun 2013
Study CompletionJan 2019
TodayJul 2026
First PostedJun 19, 2013
Enrollment StartMay 31, 2013
Primary CompletionJun 5, 2013
Study CompletionJan 29, 2019
TodayJul 2, 2026
Enrollment to primary: 4 daysPosted 13.0 years ago
Interventions
lisinoprildrug
Given PO
placebodrug
Given PO